Common steroid medications hold promise for tissue repair

May 03, 2010

A class of drugs commonly used for asthma, inflammation and skin injury also may hold promise for tissue-repairing regenerative medicine, according to Duke University Medical Center researchers.

In studies on cells from mice, the drugs, a kind of called glucocorticoids, appear to be promoting and protecting stem that perform tissue repair.

"We found that these common compounds could help to produce populations of (nerve-repairing) neuronal stem cells anad may even have a protective effect on the new stem cells, which could assist in tissue repair processes," said senior author Wei Chen, Ph.D., assistant professor in the Duke Department of Medicine. "Next we would like to study how these drugs work in specific conditions, starting with spinal cord injury repair and neural regeneration in the setting of Parkinson's disease."

The research was published online in the the week of May 3.

Chen said the findings are exciting, because millions of people have taken the glucocorticoid drugs, and the drugs are well known to be safe. He foresees new roles for these drugs to help grow new blood vessel networks after heart attack, to improve wound healing in people with diabetes, and to stimulate hair growth.

"This work is an excellent example of basic science research having the potential to positively impact patients in unexpected ways," said H. Kim Lyerly, M.D., George Barth Geller Professor of Research in Cancer and Director of the Duke Comprehensive Cancer Center. "This discovery may pave the way to better therapies for conditions from spinal cord injury to neuron degeneration. In addition, it allows us to look at cancer risk and potential cancer therapies in new ways that may benefit patients and their families."

The Duke researchers were searching for a medication that activates a cell-signaling pathway called "Hedgehog" that is critical to stem cell growth. They found that these glucocorticoid drugs -- especially fluticasone, halcinonide, clobetasol and fluocinonide -- stimulated a receptor called Smoothened, which in turn helped to stimulate stem cell growth and protect neuronal cells.

Chen said Smoothened works by activating the Hedgehog pathway, which in turn regulates , and is important in embryo growth and mature tissue integrity and repair. Although genetic mutations of Smoothened are linked with skin cancer, these drugs that activate the pathway have a proven safety record over more than two decades. Researchers and clinicians have not found any evidence of cancer association with glucocorticoid drugs, Chen said.

The PNAS paper is a proof of principle that the glucocorticoids used in asthma might work for asthmatic tissue remodeling in lung injury models, Chen said. "Asthma drugs like fluticasone provide a chemical means to treat inflammation," Chen said. "No one thought that fluticasone could help asthmatic patients because it might be doing something to protect new cells."

"Using medicinal chemistry, we hope to be able to create effective and safe compounds that will be new tools for the science of regenerative medicine," Chen said.

Explore further: FDA approves new drug for rare genetic disease

Related Stories

Stem cells used to reverse paralysis in animals

Jan 28, 2009

A new study has found that transplantation of stem cells from the lining of the spinal cord, called ependymal stem cells, reverses paralysis associated with spinal cord injuries in laboratory tests. The findings show that ...

Stem cell surprise for tissue regeneration (w/ Podcast)

Jun 25, 2009

Scientists working at the Carnegie Institution's Department of Embryology, with colleagues, have overturned previous research that identified critical genes for making muscle stem cells. It turns out that ...

New properties of skin stem cells

Oct 14, 2008

Recent research from the Swedish medical university Karolinska Institutet reveals completely new properties of the skin's stem cells – discoveries that contradict previous findings. The studies, which are published in Nature Ge ...

Recommended for you

Boxed warnings are common in novel therapeutics

Aug 19, 2014

(HealthDay)—Boxed warnings are common on recent drug approvals, and many occur years after approval, according to a research letter published online Aug. 15 in JAMA Internal Medicine.

AstraZeneca says DOJ closes probe into drug trial

Aug 19, 2014

British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation into a clinical trial of the company's blood thinner Brilinta, and plans no further action.

Perampanel for epilepsy: Still no proof of added benefit

Aug 19, 2014

The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In a new early benefit assessment ...

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

fixer
2.3 / 5 (3) May 03, 2010
"Chen said the findings are exciting, because millions of people have taken the glucocorticoid drugs, and the drugs are well known to be safe."

Nonsense!

That's the most irrisponsible comment so far today.
Safe steroids indeed!
Bubbble_Guy
3 / 5 (1) May 03, 2010
I agree, nonsense. It's like kind of like saying that tomatoes are deadly poisonous because everyone that eats them will die! I expect that the real science alluded to in the article was glossed over so that the masses would find it palatable. Another article posted on physorg today talked about a safer alternative to steroids! Steroids are great, but no good for long term use. It sounds like the uses that the researchers in the article have in mind will be short term, therefore more beneficial than harmful.